- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Patent holdings for IPC class C07D 401/14
Total number of patents in this class: 19730
10-year publication summary
|
1236
|
1222
|
1440
|
1477
|
1508
|
1506
|
1699
|
1559
|
1412
|
813
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4742 |
460 |
| Boehringer Ingelheim International GmbH | 4493 |
338 |
| Novartis AG | 10262 |
333 |
| Gilead Sciences, Inc. | 2222 |
291 |
| Merck Sharp & Dohme LLC | 3734 |
285 |
| F. Hoffmann-La Roche AG | 7837 |
237 |
| Takeda Pharmaceutical Company Limited | 2712 |
225 |
| Janssen Pharmaceutica N.V. | 3168 |
222 |
| Pfizer Inc. | 3386 |
204 |
| Merck Patent GmbH | 5728 |
203 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
177 |
| Amgen Inc. | 4427 |
174 |
| Hoffmann-La Roche Inc. | 3793 |
163 |
| Genentech, Inc. | 4104 |
154 |
| AstraZeneca AB | 2814 |
147 |
| Vertex Pharmaceuticals Incorporated | 1582 |
137 |
| Syngenta Crop Protection AG | 6701 |
126 |
| Rigel Pharmaceuticals, Inc. | 507 |
117 |
| LG Chem, Ltd. | 17921 |
114 |
| Celgene Corporation | 1410 |
104 |
| Other owners | 15519 |